Tag: COVID-19
Grasim Industries, Lubrizol to kickstart construction of CPVC resin facility this year
Grasim Industries Limited and Lubrizol Manufacturing India Private Limited have reaffirmed their commitment to construct the first phase of the world's largest single-site, state-of-the-art Chlorinated ... Read More
Pfizer gets PAXLOVID FDA approval for COVID-19 in high-risk adults
Pfizer has obtained approval for PAXLOVID, an oral combination therapy of nirmatrelvir tablets and ritonavir tablets, from the US Food and Drug Administration (FDA) to ... Read More
Everest Medicines commissions mRNA vaccine production plant in Jiashan
Everest Medicines, a China-based biopharmaceutical company, has commenced operations at its mRNA vaccine production plant in Jiashan, Zhejiang Province, thereby becoming a fully-integrated biopharma. With ... Read More
FDA grants EUA for Omicron-adapted Covid-19 vaccine for children below five
Pfizer and BioNTech have received the US Food and Drug Administration (FDA) emergency use authorization (EUA) for their Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine for children ... Read More
Peregrino phase 2 project : Equinor starts production from phase 2 of offshore Brazilian field
Peregrino phase 2 project : Oil and gas company Equinor has started oil production from the phase 2 development of the Peregrino oil field in ... Read More
Visby Medical adds $35m to Series E round for PCR diagnostic technology
Visby Medical, an American medical diagnostic company, has raised an additional $35 million for its PCR diagnostic technology to take its Series E funding round ... Read More
TCS roped in by QIAGEN to drive cloud transformation journey
Tata Consultancy Services (TCS) has been roped in by QIAGEN, a Germany-based provider of sample to insights solutions in life sciences and molecular diagnostics, for ... Read More
Infosys roped in by Backcountry to create and secure digital experience
Infosys has been roped in by Backcountry, an American online retailer of outdoor gear and apparel, to help in delivering a seamless and secure digital ... Read More
AstraZeneca strikes licensing deal with RQ Bio for SARS-CoV-2 targeting mAbs
AstraZeneca has signed a licensing deal with RQ Biotechnology (RQ Bio) to gain access to a portfolio of early-stage monoclonal antibodies (mAbs) targeted against Covid-19 ... Read More
Gufic Biosciences gets DCGI nod for Thymosin Alpha-1 in Covid-19
Gufic Biosciences has secured approval from the Drugs Controller General of India (DCGI) for Thymosin Alpha-1 (Immunocin α) as an add-on therapy for the treatment ... Read More